C3i CEO Louisa Petropoulos was recently featured in Outsourced Pharma online, discussing the present and future prospects of contract research organizations and Canadian innovation, as… Read More »
Montreal, December 16, 2021 — The C3i Center (C3i) is proud to announce the participation of AstraZeneca Canada (AstraZeneca) in supporting the development of the… Read More »
MONTRÉAL QC, November 4, 2021 – C3i Center Inc. has strengthened our position as Canada’s leading one-stop contract development and manufacturing organization operating in the… Read More »
An innovative treatment for advanced metastatic HER2-positive tumours has been administered to the first patient in a phase I/II clinical trial. The investigational T-cell antigen… Read More »
C3i Center Inc (Formerly known Centre for Commercialisation of Cancer Immunotherapy) is proud to announce three new additions to its executive team. Louisa Petropoulos has… Read More »
Behind every triumphant headline announcing a new breakthrough medicine, there’s an often untold story of years or even decades of basic research in the lab,… Read More »
Reporting to the Manufacturing Lead, the Manufacturing Technologist is part of the Cellular Manufacturing Unit of C3i – the most advance production team of cells… Read More »
Reporting to the Manufacturing Lead, the Manufacturing Specialist is part of the Cellular Manufacturing Unit of C3i – the most advance production team of cells… Read More »
Reporting to the Project Lead, the lab technician is part of the Biomarkers and Diagnostic Unit (BDU) of C3i center. BDU’s missions are to provide… Read More »